Effectiveness of binders in wet granulation: A comparison using model formulations of different tabletability

Drug Development and Industrial Pharmacy

Volumn 23, Issue 8, 1997, Pages 791-808

  Becker, D ^a   Rigassi, T ^a   Bauer Brandl, A ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSIL; BINDER; CELLULOSE HP M 603; EXCIPIENT; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; L HPC LH 11; LACTOSE; LYCATAB DSH; LYCATAB PGS; MAGNESIUM STEARATE; MALTODEXTRIN; MICROCRYSTALLINE CELLULOSE; PARACETAMOL; PLACEBO; POVIDONE; PVP K 30 PH; PVP XL; STARCH; UNCLASSIFIED DRUG;

APPARATUS; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG GRANULATION; MODEL; PARTICLE SIZE; TABLET DISINTEGRATION TIME; TABLET FRIABILITY; TABLET MANUFACTURE; TABLET PROPERTY; WETTABILITY;

EID: 0030845579     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709150550     Document Type: Article

References (21)

1. E. Horisawa, A. Komura, K. Danjo, and A. Otsuka, Chem. Pharm. Bull. 41, 1428-1433 (1993).
2. G. D. D'Alonzo, R. E. O'Connor, and J. B. Schwartz, Drug Dev. Ind. Pharm. 16, 1931-1944 (1990).
3. Rote Liste 1996, published by Bundesverband der Pharmazeutischen Industrie BPI, Frankfurt a.M., Germany.
4. H. G. Kristensen, P. Hom, T. Schaefer, Powder Technol., 44, 239 (1985).
5. T. Cutt, J. T. Fell, P. J. Rue, M. S. Spring, Int. J. Pharmaceutics, 33, 81-87 (1986).
6. L. Zajic, G. Buckton, Int. J. Pharmaceutics, 59, 155-164 (1990).
7. M. Wikberg, G. Alderborn, Pharm. Research, 10, 88-94 (1993).
8. K. Held, U. Kopp, I. Kilchmann-Bohli, and H. Sucker, Pharm. Ind. 55, 171-175 (1993).
9. Documentation from Sotax. Flowtest FT 300, p. 4.
10. Brochure from ShinEtsu, Low-Substituted Hydroxypropyl Cellulose, p. 7, Fig. 4, and p. 13, Fig. 13.
11. Brochure from ShinEtsu, Low-Substituted Hydroxypropyl Cellulose, p. 5, Table 3.
12. Documentation from Roquette Fréres, Lille, France: Lycatab™ DSH, p. 5.
13. Documentation from Roquette Fréres, Lille, France: Lycatab™ PGS, Bindemittel für die Feuchtgranulierung, p. 3.
14. P. Soyeux, A. Delacourte, B. Delie, B. Boniface, S.T.P. Pharma Sciences, 4, 324-328 (1994).
15. C. W. Symecko, A. J. Romero, and C. T. Rhodes, Drug Dev. Ind. Pharm., 19, 1131-1141 (1993).
16. R. Acquier, H. Hamandi, H. Maillols, and H. Delonca, Pharm. Acta Helv., 67, 315-320 (1992).
17. C. W. Symercko, C. T. Rhodes, Binding Performance of Pregelatinized Starches, Proc. 1st World Meeting APGI/APV, Budapest, 9-11 May 1995, 145-146.
18. Documentation from Roquette Fréres, Lille, France: Lycatab™ PGS, Bindemittel für die Feuchtgranulierung, p. 6.
19. A. Delacourte, J. F. Saint-Pol, J. C. Guyot, H. Dupas, and B. Delie, Pharm. Acta Helv., 67, 308-314 (1992).
20. Brochure from ShinEtsu, Low-Substituted Hydroxypropyl Cellulose, p. 7, Fig. 3 and Fig. 4.
21. Drug Development and Industrial Pharmacy, 23(8), 809-816 (1997)